[June 17, 2013] Chelsea Therapeutics International Up 10.2%, Shares Break Through Resistance (CHTP) Tweet Jun 17, 2013 (SmarTrend(R) Spotlight via COMTEX) -- Chelsea Therapeutics International (NASDAQ:CHTP) is one of today's best performing low-priced stocks, up 10.2% to $2.71 on 1.2x average daily volume. Chelsea Therapeutics International has traded 1.0 million shares thus far today, vs. average volume of 839,000 shares per day. The stock has outperformed the Dow (10.2% to the Dow's 1.1%) and outperformed the S&P 500 (10.2% to the S&P's 1.1%) during today's trading. There is potential upside of 70.7% for shares of Chelsea Therapeutics International based on a current price of $2.71 and an average consensus analyst price target of $4.62. The stock should discover initial support at its 50-day moving average (MA) of $1.97 and subsequent support at its 200-day MA of $1.46. Over the past year, Chelsea Therapeutics International has traded in a range of $0.70 to $2.75 and is now at $2.71, 287% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.5% while the 200-day MA has risen 2.6%. Chelsea Therapeutics International Ltd. is a biopharmaceutical company developing a pipeline of low toxicity antifolate compounds engineered to have anti-inflammatory and anti-tumor activity. The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders. SmarTrend recommended that subscribers consider buying shares of Chelsea Therapeutics International on February 20th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $1.64. Since that recommendation, shares of Chelsea Therapeutics International have risen 50.5%. We continue to monitor CHTP for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]